Cargando…

A bacteriophage journey at the European Medicines Agency

The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy.

Detalles Bibliográficos
Autores principales:	Debarbieux, Laurent, Pirnay, Jean-Paul, Verbeken, Gilbert, De Vos, Daniel, Merabishvili, Maia, Huys, Isabelle, Patey, Olivier, Schoonjans, Dirk, Vaneechoutte, Mario, Zizi, Martin, Rohde, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812529/ https://www.ncbi.nlm.nih.gov/pubmed/26656541 http://dx.doi.org/10.1093/femsle/fnv225

Ejemplares similares

Stability of bacteriophages in burn wound care products
por: Merabishvili, Maia, et al.
Publicado: (2017)

Call for a Dedicated European Legal Framework for Bacteriophage Therapy
por: Verbeken, Gilbert, et al.
Publicado: (2014)

Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii
por: Merabishvili, Maia, et al.
Publicado: (2014)

Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)
por: Merabishvili, Maia, et al.
Publicado: (2013)

Evaluation of the Stability of Bacteriophages in Different Solutions Suitable for the Production of Magistral Preparations in Belgium
por: Duyvejonck, Hans, et al.
Publicado: (2021)

Taking Bacteriophage Therapy Seriously: A Moral Argument
por: Verbeken, Gilbert, et al.
Publicado: (2014)

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)
por: Duyvejonck, Hans, et al.
Publicado: (2019)

Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany
por: Merabishvili, Maia, et al.
Publicado: (2012)

Quality and Safety Requirements for Sustainable Phage Therapy Products
por: Pirnay, Jean-Paul, et al.
Publicado: (2015)

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
por: Merabishvili, Maya, et al.
Publicado: (2009)

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report
por: Jennes, Serge, et al.
Publicado: (2017)

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis
por: Fauconnier, Alan, et al.
Publicado: (2020)

The Magistral Phage
por: Pirnay, Jean-Paul, et al.
Publicado: (2018)

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
por: Rohde, Christine, et al.
Publicado: (2018)

Microbiological and Molecular Assessment of Bacteriophage ISP for the Control of Staphylococcus aureus
por: Vandersteegen, Katrien, et al.
Publicado: (2011)

On the interactions between virulent bacteriophages and bacteria in the gut
por: Maura, Damien, et al.
Publicado: (2012)

Business oriented EU human cell and tissue product legislation will adversely impact Member States’ health care systems
por: Pirnay, Jean-Paul, et al.
Publicado: (2013)

Beware of the commercialization of human cells and tissues: situation in the European Union
por: Pirnay, Jean-Paul, et al.
Publicado: (2012)

The Diversity of Bacterial Lifestyles Hampers Bacteriophage Tenacity
por: Lourenço, Marta, et al.
Publicado: (2018)

“I will survive”: A tale of bacteriophage-bacteria coevolution in the gut
por: De Sordi, Luisa, et al.
Publicado: (2018)

Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against Bacteroides fragilis
por: Bakuradze, Nata, et al.
Publicado: (2023)

Bacteriophage Application for Difficult-To-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol
por: Onsea, Jolien, et al.
Publicado: (2019)

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center
por: De Vos, Daniel, et al.
Publicado: (2016)

Characterization of Salmonella Isolates from Various Geographical Regions of the Caucasus and Their Susceptibility to Bacteriophages
por: Makalatia, Khatuna, et al.
Publicado: (2020)

Screening of Anorectal and Oropharyngeal Samples Fails to Detect Bacteriophages Infecting Neisseria gonorrhoeae
por: Laumen, Jolein Gyonne Elise, et al.
Publicado: (2022)

The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy
por: Marchi, Jacopo, et al.
Publicado: (2023)

Isolation and Characterization of Lytic Pseudomonas aeruginosa Bacteriophages Isolated from Sewage Samples from Tunisia
por: Akremi, Ismahen, et al.
Publicado: (2022)

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators
por: Saesen, Robbe, et al.
Publicado: (2023)

The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams
por: Dufour, Nicolas, et al.
Publicado: (2017)

Pseudomonas aeruginosa Population Structure Revisited
por: Pirnay, Jean-Paul, et al.
Publicado: (2009)

Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation
por: Paul, Kevin, et al.
Publicado: (2021)

Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro
por: Dufour, Nicolas, et al.
Publicado: (2016)

Comparative transcriptomics analyses reveal the conservation of an ancestral infectious strategy in two bacteriophage genera
por: Blasdel, Bob G, et al.
Publicado: (2017)

A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient
por: Lebeaux, David, et al.
Publicado: (2021)

EHPnet: European Chemicals Agency
por: Dooley, Erin E.
Publicado: (2008)

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination
por: Ferran, Aude A., et al.
Publicado: (2022)

Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)
por: Onsea, Jolien, et al.
Publicado: (2021)

Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection
por: Racenis, Karlis, et al.
Publicado: (2023)

Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention
por: Morello, Eric, et al.
Publicado: (2011)

Isolation and Characterization of Bacteriophages That Infect Citrobacter rodentium, a Model Pathogen for Intestinal Diseases
por: Mizuno, Carolina M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p51se63qe3kcog1eau12a8tf4b